Nephros Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Due to inventory build up in the second quarter 2026, Nephros Inc 's inventory turnover ratio sequentially decreased to 2.54 in the second quarter 2026, otherwise the ratio remained above the average, as NEPH's markets remain strong.Nephros Inc 's average inventory processing period in the Jun 30 2026 quarter, has increased to 144 days, from 135 days, in the Mar 31 2026 quarter.

Within Healthcare sector 153 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 1046 in the first quarter 2026, to 1323.

NEPH Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Nephros Inc Market Share?

What is Inventory Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Inventory Turnover▼

None ▼

Inventory Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

NEPH Inventory Turnover Ratio	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Inventory Growth	103.26 %	85.21 %	23.59 %	-11.65 %	-20.19 %
Y / Y Cost of Sales Growth	99.1 %	100 %	100 %	0 %	0 %
Inventory Turnover Ratio (TTM)	2.54	2.71	2.76	2.1	2.02
NEPH's Total Ranking	# 1323	# 1046	# 1026	# 961	# 1307
Average inventory processing period	143	135	132	174	181
Seq. Inventory Growth	25.64 %	11.97 %	18.04 %	22.4 %	14.48 %
Seq. Cost of Sales Growth	-0.45 %	-50 %	300 %	0 %	0 %

Inventory Turnover Ratio Company Ranking
Within:	No.
Medical Equipment & Supplies Industry	# 63
Healthcare Sector	# 154
Overall Market	# 1323

Inventory Turnover Ratio Statistics
High	Average	Low
4.24	1.99	0.75
(Mar 31 2015)		(Mar 31 2021)

NEPH Company Profile >> Back to NEPH Efficiency Comparisons >> Compare NEPH Inventory Turnover Ratio to its Competitors

Financial Statements
Nephros Inc 's Inventories	$ 5 Millions	Visit NEPH's Balance sheet
Nephros Inc 's Cost of Revenues TTM	$ 9 Millions	Visit NEPH's Income Statement
What are NEPH's Sales?		Visit NEPH's Sales by Segment

Other Inventory Turnover Ratios
Nephros Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Medical Equipment & Supplies Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
NEPH's Inventory Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for NEPH's Competitors
Inventory Turnover Ratio for NEPH's Suppliers
Inventory Turnover Ratio for NEPH's Customers

You may also want to know
NEPH's Sales Growth Rates	NEPH's Pe Price to earnings ratio	NEPH's Receivables Turnover Ratio	NEPH's Stock Quote
NEPH's Net Income Growth Rates	NEPH's Ps Price to Sales ratio	NEPH's Sales per Employee	NEPH's Asset Turnover Ratio
NEPH's Net Margin	NEPH's Pb Price to Book ratio	NEPH's Financial Strength Ratios	NEPH's Dividend Payout Ratio

Companies with similar Inventory Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector	Inventory Turnover Ratio	Cost of revenues at quarter ending Jun 30 2026	Inventories at quarter ending Jun 30 2026
Opko Health Inc	5.42	$ 348.206 Millions	$ 64 Millions
Charles River Laboratories International inc	5.39	$ 1,761.363 Millions	$ 327 Millions
Tactile Systems Technology Inc	5.12	$ 81.349 Millions	$ 16 Millions
Integer Holdings Corporation	5.03	$ 1,369.168 Millions	$ 272 Millions
Collegium Pharmaceutical Inc	4.99	$ 293.290 Millions	$ 59 Millions
Harrow Inc	4.93	$ 73.636 Millions	$ 15 Millions
Ufp Technologies Inc	4.93	$ 452.046 Millions	$ 92 Millions
Veracyte Inc	4.84	$ 102.741 Millions	$ 21 Millions
West Pharmaceutical Services Inc	4.72	$ 2,103.100 Millions	$ 445 Millions
Henry Schein Inc	4.68	$ 9,342.000 Millions	$ 1,997 Millions
Guardant Health Inc	4.53	$ 413.947 Millions	$ 91 Millions
Idexx Laboratories Inc	4.44	$ 1,714.440 Millions	$ 386 Millions
Cryoport inc	4.40	$ 98.679 Millions	$ 22 Millions
Envista Holdings Corporation	4.37	$ 1,278.500 Millions	$ 293 Millions
Adc Therapeutics Sa	4.17	$ 5.806 Millions	$ 1 Millions
Scilex Holding Company	4.08	$ 14.867 Millions	$ 4 Millions
Medinotec Inc	4.08	$ 4.736 Millions	$ 1 Millions
Alpha Teknova Inc	4.08	$ 28.288 Millions	$ 7 Millions
3m Company	4.07	$ 15,258.000 Millions	$ 3,754 Millions
Electromed Inc	4.02	$ 14.133 Millions	$ 4 Millions
Novocure Limited	4.02	$ 166.921 Millions	$ 41 Millions
Elite Pharmaceuticals Inc	3.95	$ 78.824 Millions	$ 20 Millions
Lftd Partners Inc	3.89	$ 29.233 Millions	$ 8 Millions
Pmgc Holdings Inc	3.87	$ 1.364 Millions	$ 0 Millions
Sonoma Pharmaceuticals Inc	3.83	$ 13.392 Millions	$ 3 Millions
Intelligent Bio Solutions Inc	3.80	$ 2.165 Millions	$ 1 Millions
Iridex Corp	3.80	$ 32.517 Millions	$ 9 Millions
Biocryst Pharmaceuticals Inc	3.69	$ 20.926 Millions	$ 6 Millions
Teva Pharmaceutical Industries Limited	3.66	$ 8,232.000 Millions	$ 2,250 Millions
Neuraxis Inc	3.55	$ 0.783 Millions	$ 0 Millions

Date modified: 2026-08-12T20:31:27+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.